Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, ...

Cormorant Asset Management added 251,600 shares in Rapport Therapeutics; the reported position value increased by ...

A review on autoimmune neurological diseases reveals what occurs in our body when the immune system, by mistake, produces ...

MOG antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients ...

MapLight Therapeutics is the latest biotech to want a turn with Alphabet’s AI spinout SandboxAQ. | MapLight Therapeutics is ...

Sleep is a complex biological process, with numerous evolutionarily-gained functions. Despite its indisputable biological importance, much remains unknown about sleep, including the bidirectional ...

Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional ...

A global research team co-led by VCU expert Kenneth Kendler has produced the most comprehensive genetic map so far, identifying five families of disorders that show a high degree of overlap. An intern ...

Chronic sleep deprivation acts as a systemic stressor, elevating risks for cardiovascular disease and metabolic dysregulation while impairing cognitive function.

SandboxAQ and MapLight Therapeutics, Inc. (Nasdaq: MPLT) announced today that the companies have entered into a strategic collaboration to discover and develop potential first-in-class therapies ...

After the first live implementation phase, Neuraxpharm shared that internal demand forecasts—previously exchanged manually—are now automatically transferred to the CMO's ERP system within minutes of ...